Research Paper Volume 12, Issue 24 pp 25294—25303
Multiwalled carbon nanotubes inhibit cell migration and invasion by destroying actin cytoskeleton via mitochondrial dysfunction in ovarian cancer cells
- 1 Department of Reproductive Medicine, Linyi People's Hospital, Linyi, Shandong, China
- 2 Department of Tuberculosis, Linyi People's Hospital, Linyi, Shandong, China
- 3 Supervision of Medical Areas, Linyi People's Hospital, Linyi, Shandong, China
Received: May 10, 2020 Accepted: August 1, 2020 Published: December 3, 2020
https://doi.org/10.18632/aging.104130How to Cite
Abstract
Objective: This study aimed to investigate the effects of multiwalled carbon nanotubes (MWCNTs) on cytotoxicity and tumor metastasis in ovarian cancer cells, and further explored its mechanism.
Results: MWCNTs significantly inhibited cell viability and the clone number, increased the cell number of S phage, promoted cell apoptosis, as well as suppressed cell migration and invasion, and damaged the structure of actin cytoskeleton in a dose-dependent manner in SKOV3. Moreover, MWCNTs treatment obviously damaged the structure of actin cytoskeleton of SKOV3, and inhibited the activities of mitochondrial electron transfer chain complexes I-V.
Conclusions: MWCNTs might influence the assembly of actin cytoskeleton by disrupting mitochondrial function, thereby inhibiting migration and invasion of SKOV3.
Methods: The characterization of MWCNTs was analyzed by UV visible light absorption spectroscopy and transmission electron microscopy. SKOV3 cells were exposed to different doses of MWCNTs. Then, in vitro cytotoxicity of MWCNTs was evaluated by MTT assay, colony-forming assay, cell cycle, and cell apoptosis assay. Moreover, the effects of MWCNTs on cell migration and invasion as well as actin cytoskeleton were explored in SKOV3 cells. Furthermore, the mitochondrial membrane potential and the activities of mitochondrial electron transfer chain complexes I-V were measured.
Introduction
As one of the most common gynecological malignancies, ovarian cancer is a highly fatal female cancer [1]. Ovarian cancer statistics estimate that approximately 52,100 newly diagnosed ovarian cancer and 22,500 death caused by ovarian cancer are reported in 2015 in China [2]. Early diagnosis and effective treatment are effective methods to prevent further deterioration of ovarian cancer [3]. Nowadays, studies have reported the intensive progress in the diagnosis and treatment of ovarian cancer, which contributes to the decreasing mortality and morbidity worldwide [4, 5]. Unfortunately, despite surgery and radiotherapy are effective therapeutic methods for early-stage ovarian cancer, poor prognosis still exists in advanced ovarian cancer due to high metastasis rate [4, 5]. Therefore, it is essential to further reveal the etiology and tumorigenesis of ovarian cancer and search for novel treatment methods associated with tumor aggressiveness.
Currently, nanomaterials have been reported to be promising in cancer detection and treatment, such as imaging [6], immunodetection [7], chemotherapy [8], radiotherapy [9], and immunotherapy [10]. Carbon nanotubes (CNTs) are one class of highly attractive nanomaterials due to exceptional physicochemical properties, including low weight, high flexibility, resistance against corrosion, special electrical performance and excellent mechanical strength [11]. CNTs can result in many adverse effects in living organisms by penetrating into cells and tissues [12–14]. Particularly, multiwalled carbon nanotubes (MWCNTs) have attracted tremendous attention and displayed great application values in various fields, such as materials, information, energy and biomedicine [15]. Based on the unique mechanical strength of MWCNTs, they can be adsorbed on the surface of cell membranes to affect cell membrane stiffness and fluidity, thereby changing the biomechanical properties of cells [16]. The cell biomechanical characteristics highly influence the cell movement process by involving with cytoskeleton remodeling and cell membrane flow [16]. Several studies have proved the anti-proliferative and pro-apoptotic effects of MWCNTs through influencing microtubule function of cells [17, 18]. Moreover, only a few studies have claimed that MWCNTs may inhibit cancer cell migration [19, 20]. However, the effect and mechanism of MWCNTs in ovarian cancer has not been further investigated.
In the current study, the effects of MWCNTs on cytotoxicity and tumor metastasis were unraveled in ovarian cancer SKOV3 cells, and the potential mechanism was further explored.
Results
Characterization of MWCNT
Commercial MWCNT dispersion exhibited black appearance (Figure 1A). The optical absorption spectra of MWCNT revealed around 260 nm of absorption peaks (Figure 1B). TEM images showed the complete and visible tubular structure (Figure 1C).
Figure 1. Characterization of multiwalled carbon nanotubes (MWCNTs). (A) The appearance of commercial MWCNTs. (B) The ultraviolet visible absorption spectra of MWCNTs. (C) The representative images of MWCNTs using transmission electron microscopy.
Effect of MWCNT on cytotoxicity in SKOV3 cells
MTT assay showed that MWCNT significantly inhibited cell viability in dose-dependent manner both at 24 and 48 h, and MWCNT with a dose of less than 100 μg/mL showed more than 50% of cell viability (Figure 2A). Another ovarian cancer cell line A2780 and used MTT to detect the effect of different concentrations of MWCNTs on cell viability. Consistently, colony formation results also revealed that compared with control cells, the clone number was obviously decreased in SKOV3 cells with MWCNT in dose-dependent manner (Figure 2B). In addition, flow cytometry analysis found that MWCNT treatment prominently reduced the cell number of G0/G1 phage, while increased cell number of S phage in dose-dependent manner (p < 0.05, Figure 2C). Meanwhile, the rate of apoptotic cells was remarkably increased after MWCNT treatment in dose-dependent manner at 24 h in SKOV3 cells compared with control cells (p < 0.05, Figure 2D).
Figure 2. Multiwalled carbon nanotubes (MWCNTs) inhibits tumor growth in SKOV3 cells. (A) Cell viability of SKOV3 cells treated with different doses of MWCNTs at 24h and 48 h by MTT assay. (B) Clone number of SKOV3cells treated with different doses of MWCNTs at 24h by colony formation assay. (C) Cell cycle of SKOV3 cells treated with different doses of MWCNTs at 24h by flow cytometry analysis. (D) Cell apoptosis rate of SKOV3 cells treated with different doses of MWCNTs at 24h and 48 h by flow cytometry analysis. *P < 0.05, and **P < 0.01 vs control cells (0 μg/mL MWCNTs).
Effect of MWCNT on tumor metastasis in SKOV3 cells
Wound healing assay showed that MWCNT significantly decreased the wound closure and inhibited wound healing rate of SKOV3 cells in dose- and time-dependent manner (p < 0.05, Figure 3A), suggesting a reduced migration potential after MWCNT treatment in SKOV3 cells. Transwell assay also revealed that cell migration and invasion were dramatically inhibited in SKOV3 cells treated with MWCNT compared with control cells (p < 0.05, Figure 3B).
Figure 3. Multiwalled carbon nanotubes (MWCNTs) inhibits tumor metastasis in SKOV3 cells. (A) The wound closure and wound healing rate of SKOV3 cells treated with different doses of MWCNTs at 0, 6, 12 h and 24 h by wound healing assay. (B) Cell migration and migration rates in SKOV3 cells treated with different doses of MWCNTs by Transwell assay. *P < 0.05, **P < 0.01, and ***P < 0.001 vs control cells.
Effect of MWCNT on actin cytoskeleton of SKOV3 cells
Actin cytoskeleton is essential for cell migration and invasion; thus, actin cytoskeleton of SKOV3 cells was observed under confocal microscopy. As shown in Figure 4, the cellular cytoplasm of control cell exhibited the well-arranged actin filaments in thick bundles. In contrast, MWCNT treatment damaged the structure of actin cytoskeleton of SKOV3 cells in dose-dependent manner (Figure 4).
Figure 4. Multiwalled carbon nanotubes (MWCNTs) disrupts actin cytoskeleton of SKOV3 cells. Actin cytoskeleton of SKOV3 cells treated with different doses of MWCNTs under confocal microscopy.
Effect of MWCNT on mitochondrial function of SKOV3 cells
The mitochondrial membrane potential results showed that control cells mainly presented JC-1 aggregates (red fluorescence), while increased JC-1 monomers (green fluorescence) and reduced JC-1 aggregates were observed in cells treated with MWCNT in dose-dependent manner (Figure 5A). This indicated that the treatment of MWCNTs caused a decrease in mitochondrial membrane potential. Consistently, when SKOV3 cells exposed to MWCNT for 24 h, the activities of mitochondrial electron transfer chain complexes I-V were significantly decreased in dose-dependent manner compared with un-treated cells (Figure 5B). Here, we detected the level of p-NF-κB and p-p38-MAPK, which related to mitochondrial function. MWCNTs might alter the function of mitochondria by activating MAPK signaling and NF-κB signaling. The OCR detection showed that cells treated with MWCNTs have lower mitochondrial respiration.
Figure 5. Multiwalled carbon nanotubes (MWCNTs) disrupted mitochondrial function of SKOV3 cells. (A) The mitochondrial membrane potential in SKOV3 cells treated with different doses of MWCNTs. (B) The activities of mitochondrial respiratory chain complexes I-V detected by commercially kits.
Discussion
The present study revealed that MWCNTs significantly inhibited cell viability and the clone number, increased the cell number of S phage, promoted cell apoptosis, as well as suppressed cell migration and invasion in dose-dependent manner in SKOV3 cells. Moreover, MWCNTs treatment obviously damaged the structure of actin cytoskeleton of SKOV3 cells, and inhibited the activities of mitochondrial electron transfer chain complexes I-V.
MWCNTs have widely used for various biomedical applications due to their unique physiochemical properties, and the biocompatibility and safety of MWCNTs are considered as key factors in biomedical applications. Several studies have evaluated the cytotoxicity of MWCNTs in vitro experiments. Graham et al. have reported that MWCNTs with the doses of 0-100 μg/mL exhibit similar cell viability, suggested the minimal cytotoxicity to normal MCF 10A cells as well as breast cancer cells (MDA-231 cells and MCF-7 cells) [20]. Also, García-Hevia L et al. have evaluated the toxicity of MWCNTs in different migrating cancer cells, such as glioma U87MG cells, neuroblastoma SH-SY5Y cells, cervical cancer HeLa cells, and breast cancer MCF-7 cells, and the results show no obvious toxicity when treated with 25 μg/mL of MWCNTs for 70 h [19]. In this study, we also evaluated the cytotoxicity effect of MWCNTs at different doses in SKOV3 cells. The results found that MWCNTs exhibited inhibiting effect on cell viability and the clone number in a dose-dependent manner, while more than 100 μg/mL of MWCNTs showed a low cell viability at 48 h in SKOV3 cells. Furthermore, SKOV3 cells treated with MWCNTs showed a low apoptotic rate at 20 μg/mL of MWCNTs, while S phase arrest and a high apoptotic rate were found at 100 μg/mL of MWCNTs. All these data suggested that MWCNTs with a dose of less than 100 μg/mL exhibited anti-proliferative and pro-apoptotic effects, while non-half lethal cytotoxicity effect in SKOV3 cells.
Tumor metastasis is a complex and multistep process, which includes the formation of a new microvascular network, tumor cells invading the primary organ, escaping from the primary tumor into the surrounding tissue, arresting and proliferation in a new organ [21]. High rate of tumor metastasis is considered a great challenge for cancer treatment [22]. Interestingly, previous studies have shown that MWCNTs treatment contributes to a slower migration and invasion in several cancer cells [17, 19]. Thus, we further investigated the effect of MWCNTs on cell migration and invasion in SKOV3 cells, and the results found that MWCNTs suppressed migration and invasion of SKOV3 cells. It is well-known that tumor cells undergo morphological and structural changes during metastasis, and actin cytoskeleton plays an important role in cancer progression by driving tumor cell invasion and migration [23–25]. In response to various extracellular factors and signals, a characteristic polarized morphology is firstly observed in the migrating cells [26]. Concretely, the fingerlike protrusions (filopodia) and flat membrane protrusions (lamellipodia) are extended at the cell front by driving actin assembly [26]. Then the actin cytoskeleton is connected with the extracellular matrix by cell adhesion at the leading edge of the lamellipodia, thereby leading to cell migration [26]. Importantly, the formation and rearrangement of actin cytoskeleton are induced by activated actin under external stimuli [27, 28]. Thus, this study observed the structural changes of the actin cytoskeleton by actin staining, and the results showed that MWCNTs damaged the structure of actin cytoskeleton of SKOV3 cells. Importantly, energy is necessary for the assembly of the actin cytoskeleton, and intracellular ATP is usually produced from mitochondria in mammalian cells [29]. In addition, the mitochondrial electron transfer chain complexes I-V have been suggested to play key roles in ATP synthesis [29]. Thus, mitochondrial function was investigated by the measurements of the mitochondrial membrane potential and the activities of mitochondrial electron transfer chain complexes I-V. Our study revealed that MWCNTs obviously damaged the structure of actin cytoskeleton of SKOV3 cells, and inhibited the activities of mitochondrial electron transfer chain complexes I-V. These data indicated that MWCNTs might influence the assembly of actin cytoskeleton by disrupting mitochondrial function, thereby inhibiting migration and invasion of SKOV3 cells.
In conclusion, findings from this study revealed that MWCNTs exhibit inhibiting effects in cell migration and invasion by destroying actin cytoskeleton, which might be associated with mitochondrial dysfunction.
Materials and Methods
Characterization of MWCNTs
MWCNTs with > 95% purity were purchased from XFNANO Materials Tech Co. Ltd (Nanjing, Jiangsu, China). MWCNTs were dissolved in 1% DMSO and MWCNTs suspension was prepared by sonication machine. The ultraviolet (UV) visible spectra of MWCNTs was measured by UV visible light absorption spectroscopy (Biochrom, Cambridge, UK). The morphology of MWCNTs was observed by transmission electron microscopy (TEM; HT7700; Hitachi, Japan).
Cell culture and treatment
Ovarian cancer cell line SKOV3 and A2780 were obtained from Shanghai Obio Technology Co., Ltd, and then maintained in complete DMEM medium (Gibco, Carlsbad, CA, USA) under 37° C and 5% CO2. SKOV3 and A2780 cells were exposed to different doses of MWCNT.
MTT assay
SKOV3 and A2780 cells were grown in 96-well plates, and then underwent different doses of MWCNT (1, 5, 20, 50, 100, and 200 μg/mL). After conventional incubation for 24 and 48 h, each well was added with 10 μl of MTT (5 mg/mL, Sigma) for another 4 h. Afterwards, 100 μL of dimethyl sulfoxide was added. Microplate spectrophotometer was used to evaluate cell viability based on the absorbances at 470 nm.
Colony-forming assay
SKOV3 cells were grown in 6-well plates at a density of 400 cells/well, and then underwent different dose of MWCNT (1, 5, 20, 50, 100, and 200 μg/mL) for 14 days under standard culture conditions. Then cells were fixed with absolute methanol, and incubated with crystal violet. Ultimately, the number of colonies was counted.
Flow cytometry assay
Cell cycle and apoptosis were evaluated by flow cytometry assay. SKOV3 cells were treated with different doses of MWCNT (20, 50, and 100 μg/mL) for 24 h. Trypsin was used to digest cells with various treatments, and then cells were harvested. For cell cycle assay, cells were incubated in 70% ethanol on ice for 2 h, and then stained with propidium iodide (PI) for 30 min at 37° C. For cell apoptosis, FITC-Annexin V Apoptosis kit was used. Briefly, cells were rinsed with PBS, and resuspended with Binding Buffer. Next, the cells underwent the incubation of FITC-Annexin V and PI with cells for 15 min, in turn. Flow cytometer (BD, CA, USA) was used to measure cell cycle and calculate the number of apoptotic cells.
Wound healing assay
SKOV3 cells were inoculated in 6-well plates. After growing to 60% of confluence, cells were wounded by scratching the vertical lineation using pipette tips, followed by culturing in DMEM without serum. Subsequently, cells were treated with 0, 20 and 100 μg/mL of MWCNT, respectively. The distance of the scratch was observed at 0, 6, 12 and 24 h using a light microscope (Olympus, Japan).
Transwell assay
Tumor cell invasion and migration were elevated by Transwell chambers (Corning). Concretely, the bottom compartment was added with DMEM supplemented with 10% FBS and MWCNT (20 and 100 μg/mL). SKOV3 cells were grown in the upper compartment coated with Matrigel Matrix and cultured in medium free of serum for 24 h. Subsequently, the cells in the bottom compartment were fixed and stained 4,6-diamidino-2-phenylindole. An inverted microscope (Olympus, Japan) was utilized to evaluate cell migration and invasion.
Cytoskeleton staining
SKOV3 cells were inoculated on cover slips, and then exposed to 0, 20, 50 and 100 μg/mL of MWCNT, respectively, for 24 h. The cells were then subjected to fixation using 4% paraformaldehyde and permeabilized treatment by 0.1% Triton X-100. Followed by blockage by 2% bovine serum albumin, the cells were stained with FITC-Phalloidin (actin, green) and DAPI (nucleus, blue), in turn. Finally, cell images were obtained using laser scanning confocal microscope (Olympus, Japan).
Mitochondrial membrane potential detection
Mitochondrial membrane potential depolarization was detected using commercial JC-1 kit (Beyotime). At high membrane potential, JC-1 shows red fluorescent aggregates; while JC-1 presents green fluorescent monomers at low membrane potential. Briefly, SKOV3 cells were treated with different doses of MWCNT (20, 50, and 100 μg/mL) for 24 h, and then stained with 1 ml of JC-1 dye at 37° C for 20 min. Next, cells were rinsed with JC-1 buffer, and observed under an inverted microscope (Olympus, Japan).
Activity measurements of mitochondrial respiratory chain complexes
SKOV3 cells were inoculated in 6-well plates, and treated with 0, 20, 50, and 100 μg/mL of MWCNT, respectively, for 24 h. Next, trypsin was used to digest cells with various treatments, and then cells were lysed. Subsequently, the activities of mitochondrial respiratory chain complexes I-V were detected by commercial kits (Jianchen, Nanjing, China).
Western blot analysis
The SKOV3 cells were lysed using radioimmunoprecipitation assay (RIPA) buffer (Beyotime, Shanghai, China). Total protein levels were quantified using a BCA Protein Assay kit (Pierce; Thermo Fisher Scientifc, Inc.) prior to performing immunoblot analysis. 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was used to separate protein samples (15 mg protein loaded per well) and then proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA). The membranes were blocked with 5% non-fat milk in Tris-buffered saline with 0.1% Tween 20 (TBST) at room temperature for 3 h, and then PVDF membranes were incubated with the corresponding primary antibodies (including anti- p-NF-κB, anti-p-p38-MAPK, anti-T-p38-MAPK, and anti-β-actin antibodies) at 4° C overnight. The membranes were washed three times with TBST, and then incubated with corresponding secondary antibodies at room temperature for 1 h. Finally, the protein bands were visualized using the enhanced chemiluminescence (ECL) protein detection kit (Millipore, MA, USA). The relative protein expression was analyzed using Image-Pro Plus software version 6.0 (Media Cybernetics, Inc., Rockville, MD, USA) and represented as the density ratio vs. β-actin.
Oxygen consumption rate (OCR) measurement
The Extracellular Flux Analyzer 8-well format (Seahorse Bioscience, Agilent Technologies, USA) was used to synchronously detect the oxygen consumption rate (OCR) in SKOV3 cells.
Briefly, cells were seeded onto XFp cell culture mini plates and cultured overnight. For OCR analysis, 1 μM oligomycin, 1 μM carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) and 0.5 μM antimycin A (Sigma, USA) were added into special 8-well probe plates. All measurements were performed according to the manufacturer's instructions, and the number of cells in each well was normalized.
Statistical analysis
Data were presented as the mean ± SD. One-way ANOVA followed by multiple comparison was used for data comparisons based on SPSS software. P < 0.05 was considered significant.
Author Contributions
Ping Zhang and Lijuan Wang contributed to the conception, design of the work and conducted the experiment. Lijuan Wang contributed to the collection, analysis, interpretation of data for the work. Jiangyan Teng drafted the manuscript. Ping Zhang and Jiangyan Teng critically revised the manuscript. All gave final approval and agree to be accountable for all aspects of work ensuring integrity and accuracy.
Conflicts of Interest
The authors declare no conflict of interest.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
References
- 1. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018; 68:284–96. https://doi.org/10.3322/caac.21456 [PubMed]
- 2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016; 66:115–32. https://doi.org/10.3322/caac.21338 [PubMed]
- 3. Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016; 2:16061. https://doi.org/10.1038/nrdp.2016.61 [PubMed]
-
4.
Morgan RJ
Jr , Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA, DeRosa M, Dorigo O, Gershenson DM, Gray HJ, Hakam A, et al. Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016; 14:1134–63. https://doi.org/10.6004/jnccn.2016.0122 [PubMed] - 5. Doubeni CA, Doubeni AR, Myers AE. Diagnosis and management of ovarian cancer. Am Fam Physician. 2016; 93:937–44. [PubMed]
- 6. Zhou M, Tian M, Li C. Copper-based nanomaterials for cancer imaging and therapy. Bioconjug Chem. 2016; 27:1188–99. https://doi.org/10.1021/acs.bioconjchem.6b00156 [PubMed]
- 7. Liu L, Hao Y, Deng D, Xia N. Nanomaterials-based colorimetric immunoassays. Nanomaterials (Basel). 2019; 9:316. https://doi.org/10.3390/nano9030316 [PubMed]
- 8. Pantapasis K, Anton GC, Bontas DA, Sarghiuta D, Grumezescu AM, Holban AM. (2017). Bioengineered nanomaterials for chemotherapy. Nanostructures for Cancer Therapy: Elsevier, pp. 23–49. https://doi.org/10.1016/B978-0-323-46144-3.00002-7
- 9. Song G, Cheng L, Chao Y, Yang K, Liu Z. Emerging nanotechnology and advanced materials for cancer radiation therapy. Adv Mater. 2017; 29. https://doi.org/10.1002/adma.201700996 [PubMed]
- 10. Song W, Musetti SN, Huang L. Nanomaterials for cancer immunotherapy. Biomaterials. 2017; 148:16–30. https://doi.org/10.1016/j.biomaterials.2017.09.017 [PubMed]
- 11. Park S, Srivastava D, Cho K. Generalized chemical reactivity of curved surfaces: carbon nanotubes. Nano Lett. 2003; 3:1273–77. https://doi.org/10.1021/nl0342747
- 12. Ali-Boucetta H, Nunes A, Sainz R, Herrero MA, Tian B, Prato M, Bianco A, Kostarelos K. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew Chem Int Ed Engl. 2013; 52:2274–78. https://doi.org/10.1002/anie.201207664 [PubMed]
- 13. Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich JT, et al. Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Part Fibre Toxicol. 2014; 11:6. https://doi.org/10.1186/1743-8977-11-6 [PubMed]
- 14. Sargent LM, Hubbs AF, Young SH, Kashon ML, Dinu CZ, Salisbury JL, Benkovic SA, Lowry DT, Murray AR, Kisin ER, Siegrist KJ, Battelli L, Mastovich J, et al. Single-walled carbon nanotube-induced mitotic disruption. Mutat Res. 2012; 745:28–37. https://doi.org/10.1016/j.mrgentox.2011.11.017 [PubMed]
- 15. Kumar S, Rani R, Dilbaghi N, Tankeshwar K, Kim KH. Carbon nanotubes: a novel material for multifaceted applications in human healthcare. Chem Soc Rev. 2017; 46:158–96. https://doi.org/10.1039/c6cs00517a [PubMed]
- 16. Lehman JH, Terrones M, Mansfield E, Hurst KE, Meunier V. Evaluating the characteristics of multiwall carbon nanotubes. Carbon. 2011; 49:2581–602. https://doi.org/10.1016/j.carbon.2011.03.028
- 17. Villegas JC, Álvarez-Montes L, Rodríguez-Fernández L, González J, Valiente R, Fanarraga ML. Multiwalled carbon nanotubes hinder microglia function interfering with cell migration and phagocytosis. Adv Healthc Mater. 2014; 3:424–32. https://doi.org/10.1002/adhm.201300178 [PubMed]
- 18. Rodriguez-Fernandez L, Valiente R, Gonzalez J, Villegas JC, Fanarraga ML. Multiwalled carbon nanotubes display microtubule biomimetic properties in vivo, enhancing microtubule assembly and stabilization. ACS Nano. 2012; 6:6614–25. https://doi.org/10.1021/nn302222m [PubMed]
- 19. García-Hevia L, Valiente R, Fernández-Luna JL, Flahaut E, Rodríguez-Fernández L, Villegas JC, González J, Fanarraga ML. Inhibition of cancer cell migration by multiwalled carbon nanotubes. Adv Healthc Mater. 2015; 4:1640–44. https://doi.org/10.1002/adhm.201500252 [PubMed]
- 20. Graham EG, Wailes EM, Levi-Polyachenko NH. Multi-walled carbon nanotubes inhibit breast cancer cell migration. J Biomed Nanotechnol. 2016; 12:308–19. https://doi.org/10.1166/jbn.2016.2175 [PubMed]
- 21. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. 2011; 147:275–92. https://doi.org/10.1016/j.cell.2011.09.024 [PubMed]
- 22. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006; 12:895–904. https://doi.org/10.1038/nm1469 [PubMed]
- 23. Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. 2009; 284:122–30. https://doi.org/10.1016/j.canlet.2009.02.034 [PubMed]
- 24. Nürnberg A, Kollmannsperger A, Grosse R. Pharmacological inhibition of actin assembly to target tumor cell motility. Rev Physiol Biochem Pharmacol. 2014; 166:23–42. https://doi.org/10.1007/112_2013_16 [PubMed]
- 25. Zhao H, Jiao Y, Zhang Z. Deguelin inhibits the migration and invasion of lung cancer A549 and H460 cells via regulating actin cytoskeleton rearrangement. Int J Clin Exp Pathol. 2015; 8:15582–90. [PubMed]
- 26. Le Clainche C, Carlier MF. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol Rev. 2008; 88:489–513. https://doi.org/10.1152/physrev.00021.2007 [PubMed]
- 27. Cosen-Binker LI, Kapus A. Cortactin: the gray eminence of the cytoskeleton. Physiology (Bethesda). 2006; 21:352–61. https://doi.org/10.1152/physiol.00012.2006 [PubMed]
- 28. Ammer AG, Weed SA. Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil Cytoskeleton. 2008; 65:687–707. https://doi.org/10.1002/cm.20296 [PubMed]
-
29.
Murphy E, Ardehali H, Balaban RS, DiLisa F, Dorn GW
2nd , Kitsis RN, Otsu K, Ping P, Rizzuto R, Sack MN, Wallace D, Youle RJ, and American Heart Association Council on Basic Cardiovascular Sciences, and Council on Clinical Cardiology, and Council on Functional Genomics and Translational Biology. Mitochondrial function, biology, and role in disease: a scientific statement from the American heart association. Circ Res. 2016; 118:1960–91. https://doi.org/10.1161/RES.0000000000000104 [PubMed]